Canadian Investment Regulatory Organization Trade Resumption - GLAB

Canadian Investment Regulatory Organization Trade Resumption - GLAB

Trading resumes in:

Company: Gemina Laboratories Ltd.

CSE Symbol: GLAB

All Issues: Yes

Resumption (ET): 10:30 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

Cision View original content: http://www.newswire.ca/en/releases/archive/December2025/30/c5796.html

News Provided by Canada Newswire via QuoteMedia

Gemina Laboratories Ltd.GLAB:CCCNSX:GLABNanotech Investing
GLAB:CC
The Conversation (0)
Gemina Laboratories Ltd.

Gemina Laboratories Ltd.

Keep Reading...
Sona Nanotech

Sona Nanotech Grants Options

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") to a consultant. Each option is exercisable into one common share at a price of $0.30 per share... Keep Reading...
Sona Nanotech

Sona Nanotech

Get access to more exclusive Nanotech Investing Stock profiles here Keep Reading...
Longeveron to Present at the Emerging Growth Virtual Conference on June 12, 2024

Longeveron to Present at the Emerging Growth Virtual Conference on June 12, 2024

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Emerging Growth Virtual Conference taking place June 12-13, 2024. Details for the Company's presentation: Date: Wednesday, June 12, 2024 Time:... Keep Reading...
Veru to Present at the American Diabetes Association's 84th Scientific Sessions

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that the Company will present two... Keep Reading...
Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor

Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor

Dr. Selvaggi was instrumental in the development and approval of lung cancer drugs Zykadia for Novartis and Opdivo for Bristol Myers Squibb CEL-SCI's Multikine immunotherapy improves the 5-year survival of head and neck cancer patients to 73% compared to 45% in controls and cuts the 5-year risk... Keep Reading...

Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers

VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice Additive effects were observed for VTX3232 in combination with the GLP-1 receptor agonist semaglutide across key endpoints compared to semaglutide... Keep Reading...

Latest News

More News

Interactive Chart

Latest Press Releases

Prince Silver to Expand and Accelerate Drilling Program at the Prince Silver Mine

SAGA Metals Completes Annual Work Program at North Wind Iron Ore Project & Provides Corporate Update

Radisson Reflects on a Successful 2025 and Provides 2026 Outlook

Empire Metals Limited Announces Conditional Sale of 75% of Eclipse Gold Project

Related News

Precious Metals Investing

Prince Silver to Expand and Accelerate Drilling Program at the Prince Silver Mine

Battery Metals Investing

SAGA Metals Completes Annual Work Program at North Wind Iron Ore Project & Provides Corporate Update

Precious Metals Investing

Radisson Reflects on a Successful 2025 and Provides 2026 Outlook

Base Metals Investing

Empire Metals Limited Announces Conditional Sale of 75% of Eclipse Gold Project

Precious Metals Investing

LaFleur Minerals Announces Non-Brokered Private Placement for Gross Proceeds of up to C$1,000,000

Gold Investing

Centurion Minerals: Advancing a High-potential Gold Project in the Heart of the Abitibi Region

Gold Investing

55 North Mining: High-grade Manitoba Gold Project with Exploration Upside